{
    "clinical_study": {
        "@rank": "97342", 
        "arm_group": [
            {
                "arm_group_label": "L-carnitine", 
                "arm_group_type": "Active Comparator", 
                "description": "L-carnitine 330mg, 3 tablet twice daily"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo drug, 3 tablet twice daily"
            }
        ], 
        "brief_summary": {
            "textblock": "L-carnitine and thyroid hormone tended to antagonize reciprocally in human body. Urinary\n      excretion of L-carnitine decreased in hypothyroid patients, and levothyroxine\n      supplementation increased excretion of L-carnitine. The investigators hypothesized that\n      supplying L-carnitine to hypothyroid patients with fatigue symptom could improve the quality\n      of life, and fatigue score in them. Therefore, the investigators planned to compare the\n      efficacy of L-carnitine and placebo in hypothyroid patients who had taken levothyroxine."
        }, 
        "brief_title": "Effects of L-carnitine on Hypothyroidism", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Hypothyroidism", 
        "condition_browse": {
            "mesh_term": "Hypothyroidism"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of hypothyroidism with fatigue symptom\n\n          -  Currently use of the same amount of levothyroxine over at least six months\n\n          -  Normal serum free T4 level\n\n        Exclusion Criteria:\n\n          -  Current smoker\n\n          -  Serum hemoglobin level of under 12mg/dL\n\n          -  Clinical diagnosis of diabetes mellitus or fasting serum glucose level \u2265 126mg/dL or\n             HbA1c level \u2265 6.5%\n\n          -  History of significant heart failure\n\n          -  History of large amount of alcohol consumption\n\n          -  Uncontrolled hypertension (systolic blood pressure \u2265 160 millimeter of mercury (mmHg)\n             or diastolic blood pressure \u2265 100 mmHg\n\n          -  pregnant, or planning to be pregnant, or breast feeding women\n\n          -  aspartate aminotransferase (AST) or alanine aminotransferase (ALT) \u2265 2 times of\n             normal limit\n\n          -  serum Cr level > 2.0mg/dL"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01769157", 
            "org_study_id": "LC-TH-1101"
        }, 
        "intervention": [
            {
                "arm_group_label": "L-carnitine", 
                "intervention_name": "L-carnitine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Carnitine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Korea University Anam Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Single-center, Randomized, Double-Blinded, Comparative Study of the Effectiveness of L-carnitine in Patients'Fatigue Degree Changing With Hypothyroidism Who Take Levothyroxine", 
        "other_outcome": {
            "description": "measure thyroid-stimulating hormone and free T4 at baseline and 12 weeks", 
            "measure": "thyroid function test", 
            "safety_issue": "No", 
            "time_frame": "baseline and 12 weeks"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Change from Baseline in Fatigue severity scale at 12 weeks (scoring `fatigue severity scale` at baseline and 12 weeks)", 
            "measure": "Fatigue Severity scale", 
            "safety_issue": "Yes", 
            "time_frame": "baseline and 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01769157"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Korea University Anam Hospital", 
            "investigator_full_name": "Sin Gon Kim", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Change from Baseline in Wessely and Powell score at 12 weeks (scoring `Wessely and Powell score` at baseline and 12 weeks)", 
            "measure": "Wessely and Powell score", 
            "safety_issue": "Yes", 
            "time_frame": "baseline and 12 weeks"
        }, 
        "source": "Korea University Anam Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "IlDong Pharmaceutical Co Ltd", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Korea University Anam Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}